Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our internal colleagues in human health and with many external partners to deliver breakthrough animal health therapies, and we maximize our ability to enhance the wellbeing of animals by focusing on areas that will impact the greatest number of animals. Our broad portfolio of veterinary therapeutics, parasiticides and vaccines reflects Boehringer Ingelheim’s strong commitment to delivering value through innovation.
We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species. Our dedicated Research teams work together with our human pharma and animal health colleagues, as well as with numerous external partners to identify, validate and bring new and innovative treatment pathways and modalities into our pipeline for development into game-changing veterinary medicines.
In the Development phase, we focus on ensuring excellence in efficacy and safety for new products and delivery systems, as well as extending the benefits of our existing products with the addition of new species or claims.
While we are proud of our past successes – with products such as Metacam®, Vetmedin®, Previcox® and Semintra® – we know that science and technology advance rapidly, and we are open to new modalities, new ways of working and new opportunities to partner with others, internally and externally, to find solutions for some of the biggest challenges of today and tomorrow, such as new and advanced therapies for management of pain and chronic diseases.
